| 0 |
NONTHERAPEUTIC AGENT URINE POSITIVE |
54 |
0.5294 |
| 1 |
NONTHERAPEUTIC AGENT BLOOD POSITIVE |
10 |
0.3571 |
| 2 |
BRIEF PSYCHOTIC DISORDER WITHOUT MARKED STRESSORS |
1 |
0.2500 |
| 3 |
HEAVY METAL ABNORMAL |
3 |
0.2308 |
| 4 |
CONTRAST MEDIA TOXICITY |
29 |
0.2283 |
| 5 |
GADOLINIUM DEPOSITION DISEASE |
97 |
0.1754 |
| 6 |
CONTRAST MEDIA DEPOSITION |
53 |
0.1683 |
| 7 |
SCAN WITH CONTRAST |
3 |
0.1579 |
| 8 |
BLOOD HEAVY METAL ABNORMAL |
2 |
0.1538 |
| 9 |
HEAVY METAL INCREASED |
3 |
0.1364 |
| 10 |
CYTOKINE INCREASED |
14 |
0.1037 |
| 11 |
ALK GENE REARRANGEMENT POSITIVE |
1 |
0.1000 |
| 12 |
BLOOD HEAVY METAL INCREASED |
5 |
0.0714 |
| 13 |
CONTRAST MEDIA REACTION |
168 |
0.0711 |
| 14 |
CRAMP-FASCICULATION SYNDROME |
2 |
0.0667 |
| 15 |
HAIR METAL TEST ABNORMAL |
2 |
0.0645 |
| 16 |
CONTRAST MEDIA ALLERGY |
115 |
0.0627 |
| 17 |
MUCOSAL IRRITATION |
2 |
0.0606 |
| 18 |
STERTOR |
2 |
0.0571 |
| 19 |
BILE OUTPUT DECREASED |
1 |
0.0435 |
| 20 |
MUSCLE FIBROSIS |
3 |
0.0411 |
| 21 |
BIOPSY THYROID GLAND ABNORMAL |
1 |
0.0400 |
| 22 |
GINGIVAL PRURITUS |
3 |
0.0349 |
| 23 |
OXYGEN SATURATION IMMEASURABLE |
3 |
0.0273 |
| 24 |
ANTI-ERYTHROCYTE ANTIBODY POSITIVE |
2 |
0.0244 |
| 25 |
SCLERAL OEDEMA |
2 |
0.0241 |
| 26 |
HYPERINTENSITY IN BRAIN DEEP NUCLEI |
2 |
0.0238 |
| 27 |
PERIHEPATIC DISCOMFORT |
2 |
0.0230 |
| 28 |
PARAESTHESIA MUCOSAL |
2 |
0.0215 |
| 29 |
BIOPSY BRAIN ABNORMAL |
1 |
0.0200 |
| 30 |
BLOOD CATECHOLAMINES DECREASED |
1 |
0.0196 |
| 31 |
MITOCHONDRIAL TOXICITY |
16 |
0.0195 |
| 32 |
DRUG CROSS-REACTIVITY |
3 |
0.0168 |
| 33 |
ANAPLASTIC LYMPHOMA KINASE GENE MUTATION |
1 |
0.0152 |
| 34 |
OPTIC NERVE COMPRESSION |
2 |
0.0146 |
| 35 |
CONTRAST ENCEPHALOPATHY |
4 |
0.0145 |
| 36 |
METAL POISONING |
8 |
0.0138 |
| 37 |
PARAESTHESIA EAR |
2 |
0.0136 |
| 38 |
SMALL FIBRE NEUROPATHY |
10 |
0.0136 |
| 39 |
PROSOPAGNOSIA |
2 |
0.0125 |
| 40 |
BONE HYPERTROPHY |
2 |
0.0124 |
| 41 |
SKIN FIBROSIS |
6 |
0.0124 |
| 42 |
BURKHOLDERIA INFECTION |
1 |
0.0120 |
| 43 |
CIRCUMORAL OEDEMA |
4 |
0.0115 |
| 44 |
THYMUS DISORDER |
2 |
0.0105 |
| 45 |
BLOOD CORTICOTROPHIN ABNORMAL |
1 |
0.0104 |
| 46 |
SICCA SYNDROME |
2 |
0.0104 |
| 47 |
AUTOIMMUNE ENCEPHALOPATHY |
1 |
0.0099 |
| 48 |
LOSS OF PROPRIOCEPTION |
3 |
0.0093 |
| 49 |
HEMIANAESTHESIA |
7 |
0.0088 |
| 50 |
LARYNX IRRITATION |
2 |
0.0085 |
| 51 |
BIOPSY SKIN ABNORMAL |
2 |
0.0083 |
| 52 |
CALCIUM IONISED DECREASED |
2 |
0.0082 |
| 53 |
MYOSCLEROSIS |
3 |
0.0081 |
| 54 |
BURKHOLDERIA TEST POSITIVE |
1 |
0.0081 |
| 55 |
NASAL PRURITUS |
10 |
0.0080 |
| 56 |
INCISION SITE DISCHARGE |
2 |
0.0079 |
| 57 |
VIBRATORY SENSE INCREASED |
2 |
0.0079 |
| 58 |
SUPERFICIAL VEIN PROMINENCE |
2 |
0.0078 |
| 59 |
AORTIC INTRAMURAL HAEMATOMA |
1 |
0.0077 |
| 60 |
BLOOD PRESSURE IMMEASURABLE |
11 |
0.0072 |
| 61 |
URTICARIA |
1188 |
0.0071 |
| 62 |
TONGUE PRURITUS |
6 |
0.0070 |
| 63 |
NEPHROGENIC SYSTEMIC FIBROSIS |
21 |
0.0069 |
| 64 |
MITOCHONDRIAL CYTOPATHY |
3 |
0.0068 |
| 65 |
RESPIRATORY TRACT OEDEMA |
5 |
0.0067 |
| 66 |
SIMILAR REACTION ON PREVIOUS EXPOSURE TO DRUG |
2 |
0.0065 |
| 67 |
FOAMING AT MOUTH |
13 |
0.0064 |
| 68 |
SKIN TEST POSITIVE |
6 |
0.0064 |
| 69 |
SNEEZING |
140 |
0.0062 |
| 70 |
NON-CARDIOGENIC PULMONARY OEDEMA |
6 |
0.0057 |
| 71 |
BURNING SENSATION MUCOSAL |
2 |
0.0057 |
| 72 |
ORAL PRURITUS |
13 |
0.0057 |
| 73 |
URINARY TRACT INFLAMMATION |
2 |
0.0056 |
| 74 |
TRANCE |
2 |
0.0055 |
| 75 |
PANCREATIC ENLARGEMENT |
2 |
0.0054 |
| 76 |
NEUROBLASTOMA |
2 |
0.0052 |
| 77 |
ADMINISTRATION RELATED REACTION |
1 |
0.0051 |
| 78 |
URINE ANALYSIS ABNORMAL |
15 |
0.0050 |
| 79 |
PERIPHERAL CIRCULATORY FAILURE |
2 |
0.0049 |
| 80 |
VOMITING PROJECTILE |
14 |
0.0048 |
| 81 |
BREAST NECROSIS |
1 |
0.0048 |
| 82 |
LIP PRURITUS |
4 |
0.0047 |
| 83 |
HAEMANGIOMA OF SKIN |
2 |
0.0046 |
| 84 |
HYPERAEMIA |
9 |
0.0046 |
| 85 |
MUSCLE CONTRACTIONS INVOLUNTARY |
16 |
0.0045 |
| 86 |
THROAT TIGHTNESS |
120 |
0.0044 |
| 87 |
PHARYNGEAL PARAESTHESIA |
7 |
0.0044 |
| 88 |
SUSPECTED PRODUCT QUALITY ISSUE |
8 |
0.0044 |
| 89 |
EAR PRURITUS |
15 |
0.0043 |
| 90 |
MASTOCYTOSIS |
2 |
0.0042 |
| 91 |
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL |
6 |
0.0041 |
| 92 |
THROAT IRRITATION |
184 |
0.0041 |
| 93 |
SENSORIMOTOR DISORDER |
2 |
0.0040 |
| 94 |
URINARY TRACT PAIN |
2 |
0.0040 |
| 95 |
ORBITAL OEDEMA |
2 |
0.0040 |
| 96 |
B-CELL APLASIA |
1 |
0.0039 |
| 97 |
SKIN CANDIDA |
2 |
0.0038 |
| 98 |
OROPHARYNGEAL DISCOMFORT |
34 |
0.0038 |
| 99 |
PULSE ABNORMAL |
9 |
0.0037 |
| 100 |
JOINT CONTRACTURE |
4 |
0.0037 |
| 101 |
BLOOD GASES ABNORMAL |
2 |
0.0037 |
| 102 |
ARTERIOVENOUS FISTULA OPERATION |
1 |
0.0037 |
| 103 |
HYPERTROPHY |
2 |
0.0037 |
| 104 |
PILOERECTION |
4 |
0.0037 |
| 105 |
BLOOD PH INCREASED |
2 |
0.0036 |
| 106 |
SKIN HYPERTROPHY |
10 |
0.0036 |
| 107 |
AGONAL RESPIRATION |
1 |
0.0035 |
| 108 |
SEIZURE LIKE PHENOMENA |
6 |
0.0035 |
| 109 |
BINOCULAR EYE MOVEMENT DISORDER |
1 |
0.0035 |
| 110 |
LARYNGEAL STENOSIS |
2 |
0.0035 |
| 111 |
ALLODYNIA |
4 |
0.0034 |
| 112 |
DOSE CALCULATION ERROR |
2 |
0.0034 |
| 113 |
HYPOAESTHESIA EYE |
2 |
0.0034 |
| 114 |
EAR SWELLING |
7 |
0.0033 |
| 115 |
ANAL SQUAMOUS CELL CARCINOMA |
1 |
0.0032 |
| 116 |
MEAN CELL VOLUME DECREASED |
5 |
0.0032 |
| 117 |
VASCULAR PAIN |
3 |
0.0031 |
| 118 |
LARYNGEAL DISCOMFORT |
2 |
0.0031 |
| 119 |
SUBCUTANEOUS HAEMATOMA |
4 |
0.0031 |
| 120 |
BLADDER IRRITATION |
2 |
0.0031 |
| 121 |
DRUG CLEARANCE DECREASED |
4 |
0.0031 |
| 122 |
INJECTION RELATED REACTION |
5 |
0.0030 |
| 123 |
SPUTUM RETENTION |
3 |
0.0030 |
| 124 |
SPUTUM ABNORMAL |
2 |
0.0030 |
| 125 |
BLOOD VISCOSITY DECREASED |
1 |
0.0030 |
| 126 |
CONJUNCTIVAL OEDEMA |
3 |
0.0029 |
| 127 |
HYPOPERFUSION |
3 |
0.0029 |
| 128 |
ANOXIA |
1 |
0.0028 |
| 129 |
PERINEAL PAIN |
2 |
0.0028 |
| 130 |
GALLBLADDER ENLARGEMENT |
3 |
0.0028 |
| 131 |
SKIN WARM |
16 |
0.0027 |
| 132 |
PULSE ABSENT |
13 |
0.0027 |
| 133 |
EYE SWELLING |
100 |
0.0027 |
| 134 |
BRAIN STEM SYNDROME |
2 |
0.0027 |
| 135 |
ANISOCORIA |
1 |
0.0026 |
| 136 |
SENSATION OF FOREIGN BODY |
22 |
0.0026 |
| 137 |
CARBON DIOXIDE DECREASED |
3 |
0.0026 |
| 138 |
ADMINISTRATION SITE REACTION |
1 |
0.0026 |
| 139 |
ANAPHYLACTIC SHOCK |
66 |
0.0026 |
| 140 |
SKIN TIGHTNESS |
12 |
0.0025 |
| 141 |
MUSCLE DISCOMFORT |
2 |
0.0025 |
| 142 |
ASTROCYTOMA |
1 |
0.0025 |
| 143 |
ANAPHYLACTIC REACTION |
139 |
0.0025 |
| 144 |
PROCEDURAL NAUSEA |
2 |
0.0025 |
| 145 |
ANHIDROSIS |
1 |
0.0025 |
| 146 |
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT |
2 |
0.0024 |
| 147 |
LARYNGEAL OEDEMA |
15 |
0.0024 |
| 148 |
LIP DISCOLOURATION |
3 |
0.0024 |
| 149 |
AMAUROSIS |
2 |
0.0024 |
| 150 |
CEREBRAL VENOUS SINUS THROMBOSIS |
2 |
0.0024 |
| 151 |
INJECTION SITE COLDNESS |
2 |
0.0024 |
| 152 |
BLOOD HOMOCYSTEINE INCREASED |
1 |
0.0023 |
| 153 |
FEELING HOT |
142 |
0.0023 |
| 154 |
UNRESPONSIVE TO STIMULI |
59 |
0.0023 |
| 155 |
NASAL OEDEMA |
4 |
0.0022 |
| 156 |
ALLERGY TEST POSITIVE |
1 |
0.0022 |
| 157 |
ANTI-THYROID ANTIBODY POSITIVE |
1 |
0.0022 |
| 158 |
PHARYNGEAL HYPOAESTHESIA |
2 |
0.0022 |
| 159 |
ELECTRIC SHOCK SENSATION |
6 |
0.0021 |
| 160 |
ADRENAL NEOPLASM |
1 |
0.0021 |
| 161 |
GENERALISED ERYTHEMA |
12 |
0.0021 |
| 162 |
BLOOD ALKALINE PHOSPHATASE DECREASED |
2 |
0.0021 |
| 163 |
SKIN TEXTURE ABNORMAL |
2 |
0.0021 |
| 164 |
FINE MOTOR SKILL DYSFUNCTION |
6 |
0.0021 |
| 165 |
IDIOSYNCRATIC DRUG REACTION |
2 |
0.0020 |
| 166 |
STRIDOR |
6 |
0.0020 |
| 167 |
MUSCLE TWITCHING |
47 |
0.0020 |
| 168 |
ARTERIOVENOUS FISTULA |
1 |
0.0020 |
| 169 |
LIP SWELLING |
67 |
0.0020 |
| 170 |
SALIVARY HYPERSECRETION |
20 |
0.0020 |
| 171 |
RENAL PAIN |
21 |
0.0020 |
| 172 |
EYELID OEDEMA |
23 |
0.0020 |
| 173 |
SUSPECTED PRODUCT CONTAMINATION |
2 |
0.0020 |
| 174 |
PERIORBITAL SWELLING |
11 |
0.0019 |
| 175 |
PHARYNGEAL SWELLING |
19 |
0.0019 |
| 176 |
SKIN INDURATION |
4 |
0.0019 |
| 177 |
CONSCIOUSNESS FLUCTUATING |
2 |
0.0019 |
| 178 |
PRURITUS |
730 |
0.0019 |
| 179 |
ASPARTATE AMINOTRANSFERASE DECREASED |
1 |
0.0019 |
| 180 |
EXOPHTHALMOS |
4 |
0.0019 |
| 181 |
IRON OVERLOAD |
2 |
0.0019 |
| 182 |
ERYTHEMA |
375 |
0.0018 |
| 183 |
CHOKING SENSATION |
10 |
0.0018 |
| 184 |
RESUSCITATION |
3 |
0.0018 |
| 185 |
BLOOD MAGNESIUM ABNORMAL |
1 |
0.0018 |
| 186 |
PARAESTHESIA ORAL |
26 |
0.0018 |
| 187 |
BONE FRAGMENTATION |
1 |
0.0018 |
| 188 |
BURNOUT SYNDROME |
1 |
0.0018 |
| 189 |
COLD SWEAT |
31 |
0.0018 |
| 190 |
PHARYNGEAL OEDEMA |
27 |
0.0018 |
| 191 |
CORTISOL DECREASED |
2 |
0.0017 |
| 192 |
PO2 DECREASED |
2 |
0.0017 |
| 193 |
EXTREMITY NECROSIS |
3 |
0.0017 |
| 194 |
PRURITUS GENERALISED |
37 |
0.0017 |
| 195 |
TYPE I HYPERSENSITIVITY |
6 |
0.0017 |
| 196 |
EXTRAVASATION |
7 |
0.0017 |
| 197 |
PUSTULE |
4 |
0.0017 |
| 198 |
PRESYNCOPE |
41 |
0.0017 |
| 199 |
AGRAPHIA |
1 |
0.0017 |
| 200 |
MAGNETIC RESONANCE IMAGING ABNORMAL |
2 |
0.0017 |
| 201 |
PULSELESS ELECTRICAL ACTIVITY |
7 |
0.0017 |
| 202 |
SCLERODERMA |
6 |
0.0016 |
| 203 |
VESTIBULAR DISORDER |
2 |
0.0016 |
| 204 |
PALLOR |
44 |
0.0016 |
| 205 |
EYE MOVEMENT DISORDER |
11 |
0.0016 |
| 206 |
THROAT CLEARING |
6 |
0.0016 |
| 207 |
NASAL OBSTRUCTION |
3 |
0.0016 |
| 208 |
SWELLING OF EYELID |
10 |
0.0016 |
| 209 |
CYANOSIS |
25 |
0.0016 |
| 210 |
TESTICULAR SWELLING |
2 |
0.0016 |
| 211 |
VOMITING |
742 |
0.0016 |
| 212 |
SLOW RESPONSE TO STIMULI |
2 |
0.0015 |
| 213 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
12 |
0.0015 |
| 214 |
JOINT NOISE |
3 |
0.0015 |
| 215 |
HYPOAESTHESIA ORAL |
23 |
0.0015 |
| 216 |
EYE PRURITUS |
51 |
0.0015 |
| 217 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
26 |
0.0015 |
| 218 |
ANION GAP INCREASED |
2 |
0.0015 |
| 219 |
TACHYPNOEA |
20 |
0.0015 |
| 220 |
CORNEAL OPACITY |
2 |
0.0015 |
| 221 |
RESPIRATORY RATE INCREASED |
13 |
0.0015 |
| 222 |
ANAPHYLACTOID REACTION |
6 |
0.0015 |
| 223 |
PUSTULAR PSORIASIS |
5 |
0.0015 |
| 224 |
PERIPHERAL ARTERY THROMBOSIS |
2 |
0.0014 |
| 225 |
PERIPHERAL ARTERY OCCLUSION |
2 |
0.0014 |
| 226 |
BORDERLINE PERSONALITY DISORDER |
1 |
0.0014 |
| 227 |
CONNECTIVE TISSUE DISORDER |
2 |
0.0014 |
| 228 |
SWELLING FACE |
91 |
0.0014 |
| 229 |
BURNING SENSATION |
98 |
0.0014 |
| 230 |
BRONCHIAL WALL THICKENING |
1 |
0.0014 |
| 231 |
LANGUAGE DISORDER |
3 |
0.0014 |
| 232 |
ACCOMMODATION DISORDER |
1 |
0.0014 |
| 233 |
MUSCLE TIGHTNESS |
22 |
0.0014 |
| 234 |
AXILLARY PAIN |
2 |
0.0013 |
| 235 |
MENTAL FATIGUE |
2 |
0.0013 |
| 236 |
HYPOSMIA |
2 |
0.0013 |
| 237 |
BASOPHIL COUNT INCREASED |
1 |
0.0013 |
| 238 |
ALLERGIC COUGH |
1 |
0.0013 |
| 239 |
RENAL FUNCTION TEST ABNORMAL |
6 |
0.0013 |
| 240 |
DRY THROAT |
13 |
0.0013 |
| 241 |
BREAST CALCIFICATIONS |
1 |
0.0013 |
| 242 |
CARDIOVASCULAR INSUFFICIENCY |
2 |
0.0012 |
| 243 |
OEDEMA MOUTH |
4 |
0.0012 |
| 244 |
RETCHING |
26 |
0.0012 |
| 245 |
SUFFOCATION FEELING |
3 |
0.0012 |
| 246 |
ANAEMIA HAEMOLYTIC AUTOIMMUNE |
1 |
0.0012 |
| 247 |
RESPIRATORY DISTRESS |
33 |
0.0012 |
| 248 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
21 |
0.0012 |
| 249 |
SENSORY DISTURBANCE |
19 |
0.0012 |
| 250 |
TONGUE DISCOMFORT |
5 |
0.0012 |
| 251 |
APTYALISM |
1 |
0.0012 |
| 252 |
PHYSICAL DECONDITIONING |
3 |
0.0012 |
| 253 |
TENSION HEADACHE |
5 |
0.0012 |
| 254 |
FIXED ERUPTION |
2 |
0.0012 |
| 255 |
OCULAR HYPERAEMIA |
55 |
0.0012 |
| 256 |
LACRIMATION INCREASED |
35 |
0.0012 |
| 257 |
BLOOD CHLORIDE INCREASED |
2 |
0.0012 |
| 258 |
SWOLLEN TONGUE |
36 |
0.0012 |
| 259 |
DERMATITIS EXFOLIATIVE GENERALISED |
4 |
0.0011 |
| 260 |
GASTROINTESTINAL OEDEMA |
2 |
0.0011 |
| 261 |
FACE OEDEMA |
19 |
0.0011 |
| 262 |
INFUSION SITE EXTRAVASATION |
7 |
0.0011 |
| 263 |
NAUSEA |
890 |
0.0011 |
| 264 |
SKIN DISCOMFORT |
3 |
0.0011 |
| 265 |
ARTERIOVENOUS MALFORMATION |
1 |
0.0011 |
| 266 |
FLUSHING |
112 |
0.0011 |
| 267 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
5 |
0.0011 |
| 268 |
DISORGANISED SPEECH |
2 |
0.0011 |
| 269 |
BRAIN FOG |
17 |
0.0011 |
| 270 |
PRODUCT USE COMPLAINT |
17 |
0.0011 |
| 271 |
LYMPH NODE PAIN |
2 |
0.0011 |
| 272 |
HYPERACUSIS |
4 |
0.0011 |
| 273 |
RASH MACULAR |
37 |
0.0011 |
| 274 |
RESPIRATORY SYMPTOM |
3 |
0.0011 |
| 275 |
MENOMETRORRHAGIA |
2 |
0.0010 |
| 276 |
SKIN MASS |
7 |
0.0010 |
| 277 |
PHARYNGEAL DISORDER |
3 |
0.0010 |
| 278 |
HEAD DISCOMFORT |
18 |
0.0010 |
| 279 |
HYPERVOLAEMIA |
5 |
0.0010 |
| 280 |
RASH ERYTHEMATOUS |
48 |
0.0010 |
| 281 |
NASAL CONGESTION |
59 |
0.0010 |
| 282 |
ADMINISTRATION SITE EXTRAVASATION |
1 |
0.0010 |
| 283 |
CHEST DISCOMFORT |
102 |
0.0010 |
| 284 |
BRAIN HYPOXIA |
1 |
0.0010 |
| 285 |
MUCOSAL DRYNESS |
2 |
0.0010 |
| 286 |
MUSCLE CONTRACTURE |
2 |
0.0010 |
| 287 |
TINNITUS |
45 |
0.0010 |
| 288 |
FIBROSIS |
3 |
0.0010 |
| 289 |
HYPERAESTHESIA |
8 |
0.0010 |
| 290 |
TONGUE BITING |
2 |
0.0010 |
| 291 |
ALVEOLITIS ALLERGIC |
1 |
0.0010 |
| 292 |
BODY TEMPERATURE FLUCTUATION |
2 |
0.0010 |
| 293 |
SHOCK |
22 |
0.0010 |
| 294 |
MUSCLE ATROPHY |
12 |
0.0009 |
| 295 |
MUSCLE FATIGUE |
4 |
0.0009 |
| 296 |
PHARYNGEAL ERYTHEMA |
2 |
0.0009 |
| 297 |
TORTICOLLIS |
2 |
0.0009 |
| 298 |
ORAL DISCOMFORT |
13 |
0.0009 |
| 299 |
BLOOD PRESSURE DECREASED |
62 |
0.0009 |
| 300 |
HYPERPHOSPHATAEMIA |
2 |
0.0009 |
| 301 |
INFECTION SUSCEPTIBILITY INCREASED |
2 |
0.0009 |
| 302 |
BRONCHOSPASM |
13 |
0.0009 |
| 303 |
PHYSICAL DISABILITY |
4 |
0.0009 |
| 304 |
BONE PAIN |
53 |
0.0009 |
| 305 |
APNOEA |
7 |
0.0009 |
| 306 |
PARESIS |
2 |
0.0009 |
| 307 |
TEMPERATURE REGULATION DISORDER |
2 |
0.0009 |
| 308 |
TASTE DISORDER |
18 |
0.0009 |
| 309 |
BLOOD PRESSURE SYSTOLIC DECREASED |
4 |
0.0009 |
| 310 |
READING DISORDER |
2 |
0.0009 |
| 311 |
RESPIRATORY ARREST |
24 |
0.0009 |
| 312 |
ADMINISTRATION SITE PAIN |
1 |
0.0009 |
| 313 |
PARAESTHESIA |
136 |
0.0009 |
| 314 |
HYPERHIDROSIS |
110 |
0.0009 |
| 315 |
CONJUNCTIVAL HYPERAEMIA |
3 |
0.0008 |
| 316 |
MEDICATION RESIDUE PRESENT |
4 |
0.0008 |
| 317 |
DYSPHONIA |
49 |
0.0008 |
| 318 |
OXYGEN SATURATION DECREASED |
47 |
0.0008 |
| 319 |
BRONCHIAL HYPERREACTIVITY |
1 |
0.0008 |
| 320 |
PAINFUL RESPIRATION |
2 |
0.0008 |
| 321 |
COUGH |
231 |
0.0008 |
| 322 |
FOOD INTOLERANCE |
3 |
0.0008 |
| 323 |
EYE OEDEMA |
2 |
0.0008 |
| 324 |
VITREOUS FLOATERS |
8 |
0.0008 |
| 325 |
PULMONARY OEDEMA |
36 |
0.0008 |
| 326 |
DYSPNOEA |
455 |
0.0008 |
| 327 |
ALLERGY TO CHEMICALS |
1 |
0.0008 |
| 328 |
CARDIAC ARREST |
66 |
0.0008 |
| 329 |
SNORING |
3 |
0.0008 |
| 330 |
WHEEZING |
47 |
0.0008 |
| 331 |
CHEMICAL BURN OF SKIN |
2 |
0.0008 |
| 332 |
BRONCHIAL SECRETION RETENTION |
1 |
0.0008 |
| 333 |
CANCER PAIN |
2 |
0.0008 |
| 334 |
DYSPHAGIA |
74 |
0.0008 |
| 335 |
ADENOCARCINOMA PANCREAS |
1 |
0.0008 |
| 336 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
2 |
0.0008 |
| 337 |
RASH GENERALISED |
20 |
0.0008 |
| 338 |
PERIORBITAL OEDEMA |
4 |
0.0008 |
| 339 |
CARDIOPULMONARY FAILURE |
3 |
0.0008 |
| 340 |
URINE OUTPUT INCREASED |
2 |
0.0008 |
| 341 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
2 |
0.0008 |
| 342 |
HYPERSENSITIVITY VASCULITIS |
2 |
0.0008 |
| 343 |
YAWNING |
2 |
0.0007 |
| 344 |
FLANK PAIN |
7 |
0.0007 |
| 345 |
TRIGEMINAL NEURALGIA |
3 |
0.0007 |
| 346 |
HYPERLACTACIDAEMIA |
2 |
0.0007 |
| 347 |
LARYNGOSPASM |
2 |
0.0007 |
| 348 |
BLOOD SODIUM INCREASED |
2 |
0.0007 |
| 349 |
HEART RATE DECREASED |
26 |
0.0007 |
| 350 |
ERYTHEMA OF EYELID |
4 |
0.0007 |
| 351 |
EAR CONGESTION |
2 |
0.0007 |
| 352 |
CLONUS |
2 |
0.0007 |
| 353 |
TYPE IV HYPERSENSITIVITY REACTION |
2 |
0.0007 |
| 354 |
BRONCHIAL OBSTRUCTION |
1 |
0.0007 |
| 355 |
ALVEOLITIS |
1 |
0.0007 |
| 356 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
2 |
0.0007 |
| 357 |
INCORRECT DRUG ADMINISTRATION RATE |
3 |
0.0007 |
| 358 |
AUDITORY DISORDER |
1 |
0.0007 |
| 359 |
OXYGEN SATURATION ABNORMAL |
2 |
0.0007 |
| 360 |
HEPATIC PAIN |
3 |
0.0007 |
| 361 |
HYPOTONIA |
7 |
0.0007 |
| 362 |
NEUROLOGICAL SYMPTOM |
4 |
0.0007 |
| 363 |
ABNORMAL SENSATION IN EYE |
3 |
0.0007 |
| 364 |
MOUTH SWELLING |
4 |
0.0007 |
| 365 |
PARAPLEGIA |
2 |
0.0007 |
| 366 |
PANIC REACTION |
5 |
0.0007 |
| 367 |
VISUAL FIELD DEFECT |
5 |
0.0007 |
| 368 |
TONGUE DISORDER |
5 |
0.0007 |
| 369 |
PULMONARY PAIN |
2 |
0.0007 |
| 370 |
EAR DISCOMFORT |
7 |
0.0007 |
| 371 |
URINARY INCONTINENCE |
20 |
0.0007 |
| 372 |
FACIAL PAIN |
6 |
0.0007 |
| 373 |
CARDIO-RESPIRATORY ARREST |
28 |
0.0007 |
| 374 |
BRAIN HERNIATION |
2 |
0.0007 |
| 375 |
COGNITIVE DISORDER |
31 |
0.0007 |
| 376 |
EMERGENCY CARE |
2 |
0.0007 |
| 377 |
ACIDOSIS |
5 |
0.0007 |
| 378 |
DYSAESTHESIA |
2 |
0.0007 |
| 379 |
BLOOD PRESSURE DIASTOLIC INCREASED |
3 |
0.0006 |
| 380 |
SYNCOPE |
65 |
0.0006 |
| 381 |
ALTERED STATE OF CONSCIOUSNESS |
14 |
0.0006 |
| 382 |
BRONCHIAL DISORDER |
1 |
0.0006 |
| 383 |
ERYTHEMA MULTIFORME |
6 |
0.0006 |
| 384 |
EYELIDS PRURITUS |
2 |
0.0006 |
| 385 |
RESPIRATORY RATE DECREASED |
2 |
0.0006 |
| 386 |
LOSS OF CONSCIOUSNESS |
81 |
0.0006 |
| 387 |
TESTICULAR PAIN |
2 |
0.0006 |
| 388 |
VENTRICULAR FIBRILLATION |
7 |
0.0006 |
| 389 |
NEUROTOXICITY |
11 |
0.0006 |
| 390 |
NEURALGIA |
15 |
0.0006 |
| 391 |
DISTURBANCE IN ATTENTION |
33 |
0.0006 |
| 392 |
FEELING COLD |
17 |
0.0006 |
| 393 |
BODY TEMPERATURE DECREASED |
6 |
0.0006 |
| 394 |
BRAIN INJURY |
6 |
0.0006 |
| 395 |
CYTOKINE RELEASE SYNDROME |
12 |
0.0006 |
| 396 |
QUALITY OF LIFE DECREASED |
8 |
0.0006 |
| 397 |
HYPOTENSION |
119 |
0.0006 |
| 398 |
CONJUNCTIVITIS |
11 |
0.0006 |
| 399 |
BLOOD PH DECREASED |
1 |
0.0006 |
| 400 |
INCREASED UPPER AIRWAY SECRETION |
3 |
0.0006 |
| 401 |
PERIPHERAL COLDNESS |
8 |
0.0006 |
| 402 |
REGURGITATION |
2 |
0.0006 |
| 403 |
SEIZURE |
67 |
0.0006 |
| 404 |
HYPOPNOEA |
2 |
0.0006 |
| 405 |
FORMICATION |
4 |
0.0006 |
| 406 |
TACHYCARDIA |
51 |
0.0006 |
| 407 |
SKIN BURNING SENSATION |
41 |
0.0006 |
| 408 |
SKIN DISORDER |
19 |
0.0006 |
| 409 |
BLOOD LACTIC ACID INCREASED |
3 |
0.0006 |
| 410 |
GROIN PAIN |
5 |
0.0006 |
| 411 |
SKIN REACTION |
8 |
0.0006 |
| 412 |
PAPULE |
4 |
0.0006 |
| 413 |
INJECTION SITE EXTRAVASATION |
7 |
0.0006 |
| 414 |
BREAST CYST |
1 |
0.0006 |
| 415 |
FIBRIN D DIMER INCREASED |
2 |
0.0006 |
| 416 |
PRODUCT CONTAMINATION |
2 |
0.0006 |
| 417 |
RASH |
244 |
0.0006 |
| 418 |
HYPOAESTHESIA |
83 |
0.0006 |
| 419 |
ASTHMATIC CRISIS |
2 |
0.0005 |
| 420 |
BLOOD PHOSPHORUS DECREASED |
2 |
0.0005 |
| 421 |
VENTRICULAR ARRHYTHMIA |
2 |
0.0005 |
| 422 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
14 |
0.0005 |
| 423 |
DYSGEUSIA |
40 |
0.0005 |
| 424 |
AURA |
1 |
0.0005 |
| 425 |
RASH PAPULAR |
12 |
0.0005 |
| 426 |
ACUTE PULMONARY OEDEMA |
3 |
0.0005 |
| 427 |
PROTEIN TOTAL DECREASED |
2 |
0.0005 |
| 428 |
PARANASAL SINUS DISCOMFORT |
2 |
0.0005 |
| 429 |
TENDON PAIN |
4 |
0.0005 |
| 430 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
2 |
0.0005 |
| 431 |
SINUS CONGESTION |
7 |
0.0005 |
| 432 |
MUSCULOSKELETAL CHEST PAIN |
8 |
0.0005 |
| 433 |
RALES |
3 |
0.0005 |
| 434 |
SPINAL CORD COMPRESSION |
2 |
0.0005 |
| 435 |
HYPOXIA |
18 |
0.0005 |
| 436 |
HEPATOMEGALY |
5 |
0.0005 |
| 437 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
3 |
0.0005 |
| 438 |
DISORIENTATION |
20 |
0.0005 |
| 439 |
AZOTAEMIA |
2 |
0.0005 |
| 440 |
SPEECH DISORDER |
26 |
0.0005 |
| 441 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
2 |
0.0005 |
| 442 |
BREAST DISORDER |
1 |
0.0005 |
| 443 |
ASPHYXIA |
4 |
0.0005 |
| 444 |
PERIPHERAL ISCHAEMIA |
2 |
0.0005 |
| 445 |
DIZZINESS |
244 |
0.0005 |
| 446 |
HYPERSENSITIVITY |
90 |
0.0005 |
| 447 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
1 |
0.0005 |
| 448 |
DRY EYE |
24 |
0.0005 |
| 449 |
RASH PRURITIC |
26 |
0.0005 |
| 450 |
PETECHIAE |
5 |
0.0005 |
| 451 |
SKIN DISCOLOURATION |
22 |
0.0005 |
| 452 |
BRAIN OEDEMA |
6 |
0.0005 |
| 453 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
2 |
0.0005 |
| 454 |
LIP OEDEMA |
2 |
0.0005 |
| 455 |
RESPIRATORY DISORDER |
14 |
0.0005 |
| 456 |
METASTATIC NEOPLASM |
2 |
0.0005 |
| 457 |
SWELLING |
43 |
0.0005 |
| 458 |
DYSPHEMIA |
2 |
0.0005 |
| 459 |
MENTAL IMPAIRMENT |
11 |
0.0005 |
| 460 |
CHEST PAIN |
84 |
0.0005 |
| 461 |
GINGIVAL SWELLING |
2 |
0.0005 |
| 462 |
PALPITATIONS |
53 |
0.0005 |
| 463 |
ADVERSE REACTION |
6 |
0.0005 |
| 464 |
WHEELCHAIR USER |
2 |
0.0004 |
| 465 |
BACTERIAL TEST POSITIVE |
1 |
0.0004 |
| 466 |
THIRST |
8 |
0.0004 |
| 467 |
HEART RATE INCREASED |
44 |
0.0004 |
| 468 |
PAPILLOEDEMA |
2 |
0.0004 |
| 469 |
BLOOD LOSS ANAEMIA |
1 |
0.0004 |
| 470 |
RESPIRATORY TRACT CONGESTION |
7 |
0.0004 |
| 471 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
2 |
0.0004 |
| 472 |
MICTURITION URGENCY |
5 |
0.0004 |
| 473 |
EAR DISORDER |
2 |
0.0004 |
| 474 |
BUNDLE BRANCH BLOCK RIGHT |
2 |
0.0004 |
| 475 |
RESPIRATION ABNORMAL |
3 |
0.0004 |
| 476 |
LOCALISED OEDEMA |
2 |
0.0004 |
| 477 |
APHASIA |
13 |
0.0004 |
| 478 |
SPINAL PAIN |
5 |
0.0004 |
| 479 |
DISSEMINATED INTRAVASCULAR COAGULATION |
6 |
0.0004 |
| 480 |
DISCOMFORT |
26 |
0.0004 |
| 481 |
PHOTOPHOBIA |
8 |
0.0004 |
| 482 |
GENERALISED TONIC-CLONIC SEIZURE |
7 |
0.0004 |
| 483 |
IMPAIRED WORK ABILITY |
9 |
0.0004 |
| 484 |
MUSCULOSKELETAL DISORDER |
8 |
0.0004 |
| 485 |
RASH VESICULAR |
2 |
0.0004 |
| 486 |
RASH PUSTULAR |
3 |
0.0004 |
| 487 |
RASH MACULO-PAPULAR |
9 |
0.0004 |
| 488 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
16 |
0.0004 |
| 489 |
TREMOR |
67 |
0.0004 |
| 490 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
3 |
0.0004 |
| 491 |
EOSINOPHILIA |
7 |
0.0004 |
| 492 |
LYMPHOCYTE COUNT DECREASED |
7 |
0.0004 |
| 493 |
ECONOMIC PROBLEM |
6 |
0.0004 |
| 494 |
VISUAL IMPAIRMENT |
49 |
0.0004 |
| 495 |
DRUG ERUPTION |
7 |
0.0004 |
| 496 |
CARDIOVASCULAR DISORDER |
10 |
0.0004 |
| 497 |
SUBARACHNOID HAEMORRHAGE |
4 |
0.0004 |
| 498 |
AMMONIA INCREASED |
2 |
0.0004 |
| 499 |
PROCEDURAL COMPLICATION |
3 |
0.0004 |
| 500 |
BLOOD CHLORIDE DECREASED |
1 |
0.0004 |
| 501 |
TEMPERATURE INTOLERANCE |
4 |
0.0004 |
| 502 |
HYPERBILIRUBINAEMIA |
4 |
0.0004 |
| 503 |
FOETAL DEATH |
2 |
0.0004 |
| 504 |
DRUG SCREEN POSITIVE |
3 |
0.0004 |
| 505 |
SERUM FERRITIN INCREASED |
2 |
0.0004 |
| 506 |
NASAL DISCOMFORT |
3 |
0.0004 |
| 507 |
BLOOD ALBUMIN DECREASED |
3 |
0.0004 |
| 508 |
NYSTAGMUS |
2 |
0.0004 |
| 509 |
BLOOD POTASSIUM ABNORMAL |
1 |
0.0004 |
| 510 |
ABDOMINAL MASS |
1 |
0.0004 |
| 511 |
BEHAVIOUR DISORDER |
2 |
0.0004 |
| 512 |
ABDOMINAL RIGIDITY |
1 |
0.0004 |
| 513 |
TIC |
2 |
0.0004 |
| 514 |
MYALGIA |
62 |
0.0004 |
| 515 |
NONSPECIFIC REACTION |
2 |
0.0004 |
| 516 |
ASTHENOPIA |
2 |
0.0004 |
| 517 |
HYPERKERATOSIS |
2 |
0.0004 |
| 518 |
ANGIOEDEMA |
16 |
0.0004 |
| 519 |
OBSTRUCTIVE AIRWAYS DISORDER |
4 |
0.0004 |
| 520 |
INTRACRANIAL PRESSURE INCREASED |
2 |
0.0004 |
| 521 |
NECK PAIN |
20 |
0.0004 |
| 522 |
HEADACHE |
222 |
0.0004 |
| 523 |
PAIN IN JAW |
10 |
0.0004 |
| 524 |
PARALYSIS |
5 |
0.0003 |
| 525 |
MUSCULOSKELETAL DISCOMFORT |
6 |
0.0003 |
| 526 |
IMPAIRED QUALITY OF LIFE |
5 |
0.0003 |
| 527 |
SKIN ATROPHY |
2 |
0.0003 |
| 528 |
DIPLOPIA |
9 |
0.0003 |
| 529 |
SKIN SWELLING |
3 |
0.0003 |
| 530 |
BILIARY COLIC |
1 |
0.0003 |
| 531 |
MUSCULAR WEAKNESS |
39 |
0.0003 |
| 532 |
JOINT STIFFNESS |
9 |
0.0003 |
| 533 |
SYRINGE ISSUE |
6 |
0.0003 |
| 534 |
HYPOVOLAEMIA |
2 |
0.0003 |
| 535 |
PURPURA |
3 |
0.0003 |
| 536 |
PAIN OF SKIN |
9 |
0.0003 |
| 537 |
POLYNEUROPATHY |
4 |
0.0003 |
| 538 |
OPTIC NEURITIS |
3 |
0.0003 |
| 539 |
TENSION |
2 |
0.0003 |
| 540 |
RESPIRATORY DEPRESSION |
4 |
0.0003 |
| 541 |
ENCEPHALOPATHY |
8 |
0.0003 |
| 542 |
MUSCLE SPASTICITY |
4 |
0.0003 |
| 543 |
GLOMERULAR FILTRATION RATE DECREASED |
4 |
0.0003 |
| 544 |
CHILLS |
38 |
0.0003 |
| 545 |
CONCOMITANT DISEASE AGGRAVATED |
2 |
0.0003 |
| 546 |
BLEPHAROSPASM |
2 |
0.0003 |
| 547 |
EYE IRRITATION |
18 |
0.0003 |
| 548 |
MYDRIASIS |
4 |
0.0003 |
| 549 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
2 |
0.0003 |
| 550 |
ATELECTASIS |
3 |
0.0003 |
| 551 |
CARDIAC FLUTTER |
2 |
0.0003 |
| 552 |
INCOHERENT |
2 |
0.0003 |
| 553 |
BLOOD PRESSURE SYSTOLIC INCREASED |
6 |
0.0003 |
| 554 |
CHOKING |
6 |
0.0003 |
| 555 |
BACTERIAL SEPSIS |
1 |
0.0003 |
| 556 |
BRADYPHRENIA |
2 |
0.0003 |
| 557 |
BEDRIDDEN |
4 |
0.0003 |
| 558 |
UNEVALUABLE EVENT |
23 |
0.0003 |
| 559 |
DYSGRAPHIA |
2 |
0.0003 |
| 560 |
ARTERIOSCLEROSIS CORONARY ARTERY |
2 |
0.0003 |
| 561 |
BLOOD PRESSURE ABNORMAL |
6 |
0.0003 |
| 562 |
RESPIRATORY FAILURE |
22 |
0.0003 |
| 563 |
PAIN IN EXTREMITY |
88 |
0.0003 |
| 564 |
FEELING ABNORMAL |
71 |
0.0003 |
| 565 |
WRONG PRODUCT ADMINISTERED |
2 |
0.0003 |
| 566 |
HEMIPARESIS |
5 |
0.0003 |
| 567 |
INITIAL INSOMNIA |
3 |
0.0003 |
| 568 |
HOT FLUSH |
22 |
0.0003 |
| 569 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
1 |
0.0003 |
| 570 |
ECCHYMOSIS |
2 |
0.0003 |
| 571 |
INJECTION SITE WARMTH |
6 |
0.0003 |
| 572 |
APLASIA PURE RED CELL |
1 |
0.0003 |
| 573 |
APHONIA |
4 |
0.0003 |
| 574 |
SCRATCH |
3 |
0.0003 |
| 575 |
VISION BLURRED |
39 |
0.0003 |
| 576 |
BRADYCARDIA |
15 |
0.0003 |
| 577 |
BLOOD PRESSURE INCREASED |
43 |
0.0003 |
| 578 |
BONE LESION |
1 |
0.0003 |
| 579 |
LEUKOCYTOSIS |
5 |
0.0003 |
| 580 |
DERMATITIS BULLOUS |
2 |
0.0003 |
| 581 |
TOOTHACHE |
5 |
0.0003 |
| 582 |
RESTLESS LEGS SYNDROME |
5 |
0.0003 |
| 583 |
ARRHYTHMIA |
13 |
0.0003 |
| 584 |
RESTLESSNESS |
10 |
0.0003 |
| 585 |
MUSCLE SPASMS |
50 |
0.0003 |
| 586 |
BLINDNESS TRANSIENT |
2 |
0.0003 |
| 587 |
BLOOD PRESSURE DIASTOLIC DECREASED |
2 |
0.0003 |
| 588 |
HYPERTENSIVE CRISIS |
3 |
0.0003 |
| 589 |
MALNUTRITION |
3 |
0.0003 |
| 590 |
OCULAR DISCOMFORT |
3 |
0.0003 |
| 591 |
BLOOD CALCIUM DECREASED |
3 |
0.0003 |
| 592 |
DYSARTHRIA |
10 |
0.0003 |
| 593 |
PAROSMIA |
2 |
0.0003 |
| 594 |
OSTEOPENIA |
4 |
0.0003 |
| 595 |
RHINORRHOEA |
17 |
0.0003 |
| 596 |
VERTIGO |
16 |
0.0003 |
| 597 |
LIPASE INCREASED |
2 |
0.0003 |
| 598 |
INJECTION SITE RASH |
8 |
0.0003 |
| 599 |
AGITATION |
19 |
0.0003 |
| 600 |
LOW DENSITY LIPOPROTEIN INCREASED |
2 |
0.0003 |
| 601 |
EAR PAIN |
5 |
0.0003 |
| 602 |
PELVIC FRACTURE |
2 |
0.0003 |
| 603 |
ARTHRALGIA |
106 |
0.0003 |
| 604 |
COMA |
12 |
0.0003 |
| 605 |
PRODUCTIVE COUGH |
12 |
0.0003 |
| 606 |
MOBILITY DECREASED |
18 |
0.0003 |
| 607 |
BLOOD PRESSURE FLUCTUATION |
6 |
0.0002 |
| 608 |
ADVERSE EVENT |
23 |
0.0002 |
| 609 |
EYE PAIN |
14 |
0.0002 |
| 610 |
ASTHMA |
28 |
0.0002 |
| 611 |
MUSCLE DISORDER |
2 |
0.0002 |
| 612 |
MUSCLE INJURY |
2 |
0.0002 |
| 613 |
DYSSTASIA |
7 |
0.0002 |
| 614 |
PRODUCT USE ISSUE |
45 |
0.0002 |
| 615 |
POISONING |
3 |
0.0002 |
| 616 |
HAEMODIALYSIS |
2 |
0.0002 |
| 617 |
SKIN PLAQUE |
2 |
0.0002 |
| 618 |
BUNDLE BRANCH BLOCK LEFT |
1 |
0.0002 |
| 619 |
CIRCULATORY COLLAPSE |
4 |
0.0002 |
| 620 |
ABSCESS LIMB |
1 |
0.0002 |
| 621 |
SCAR |
4 |
0.0002 |
| 622 |
SKIN HYPERPIGMENTATION |
2 |
0.0002 |
| 623 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
3 |
0.0002 |
| 624 |
ANURIA |
2 |
0.0002 |
| 625 |
ABDOMINAL PAIN |
54 |
0.0002 |
| 626 |
BLOOD MAGNESIUM DECREASED |
2 |
0.0002 |
| 627 |
MYOPATHY |
2 |
0.0002 |
| 628 |
BALANCE DISORDER |
20 |
0.0002 |
| 629 |
PYELONEPHRITIS |
2 |
0.0002 |
| 630 |
PRODUCT PRESCRIBING ISSUE |
5 |
0.0002 |
| 631 |
DEAFNESS |
6 |
0.0002 |
| 632 |
URINE OUTPUT DECREASED |
2 |
0.0002 |
| 633 |
TUMOUR LYSIS SYNDROME |
2 |
0.0002 |
| 634 |
LUNG INFILTRATION |
2 |
0.0002 |
| 635 |
LIMB DISCOMFORT |
7 |
0.0002 |
| 636 |
ASTHENIA |
84 |
0.0002 |
| 637 |
EMOTIONAL DISTRESS |
27 |
0.0002 |
| 638 |
DRY MOUTH |
18 |
0.0002 |
| 639 |
PELVIC PAIN |
4 |
0.0002 |
| 640 |
GINGIVAL BLEEDING |
3 |
0.0002 |
| 641 |
SKIN LESION |
6 |
0.0002 |
| 642 |
INCREASED TENDENCY TO BRUISE |
2 |
0.0002 |
| 643 |
NIGHT SWEATS |
7 |
0.0002 |
| 644 |
MALAISE |
95 |
0.0002 |
| 645 |
PERICARDIAL EFFUSION |
5 |
0.0002 |
| 646 |
ARTHRITIS INFECTIVE |
1 |
0.0002 |
| 647 |
PERSONALITY CHANGE |
2 |
0.0002 |
| 648 |
BLOOD CREATININE INCREASED |
14 |
0.0002 |
| 649 |
BLISTER |
12 |
0.0002 |
| 650 |
BLOOD TEST ABNORMAL |
3 |
0.0002 |
| 651 |
HEPATIC CIRRHOSIS |
4 |
0.0002 |
| 652 |
DISEASE PROGRESSION |
25 |
0.0002 |
| 653 |
SINUS TACHYCARDIA |
3 |
0.0002 |
| 654 |
ANXIETY |
60 |
0.0002 |
| 655 |
CARDIOGENIC SHOCK |
3 |
0.0002 |
| 656 |
SUPRAVENTRICULAR TACHYCARDIA |
2 |
0.0002 |
| 657 |
LETHARGY |
12 |
0.0002 |
| 658 |
ACUTE RESPIRATORY FAILURE |
4 |
0.0002 |
| 659 |
INFLUENZA LIKE ILLNESS |
17 |
0.0002 |
| 660 |
LIVER FUNCTION TEST ABNORMAL |
6 |
0.0002 |
| 661 |
DIZZINESS POSTURAL |
2 |
0.0002 |
| 662 |
HAEMORRHOIDS |
4 |
0.0002 |
| 663 |
INJECTION SITE URTICARIA |
5 |
0.0002 |
| 664 |
HYPERTENSION |
43 |
0.0002 |
| 665 |
BREATH SOUNDS ABNORMAL |
1 |
0.0002 |
| 666 |
DISABILITY |
4 |
0.0002 |
| 667 |
SINUS DISORDER |
4 |
0.0002 |
| 668 |
PERIPHERAL SWELLING |
31 |
0.0002 |
| 669 |
AGEUSIA |
5 |
0.0002 |
| 670 |
BONE LOSS |
3 |
0.0002 |
| 671 |
TOXIC SKIN ERUPTION |
2 |
0.0002 |
| 672 |
CONFUSIONAL STATE |
32 |
0.0002 |
| 673 |
ABDOMINAL PAIN LOWER |
5 |
0.0002 |
| 674 |
HYPOTHERMIA |
2 |
0.0002 |
| 675 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
0.0002 |
| 676 |
FEEDING DISORDER |
4 |
0.0002 |
| 677 |
MOTOR DYSFUNCTION |
2 |
0.0002 |
| 678 |
OROPHARYNGEAL PAIN |
18 |
0.0002 |
| 679 |
MUSCULOSKELETAL STIFFNESS |
17 |
0.0002 |
| 680 |
SKIN ULCER |
5 |
0.0002 |
| 681 |
GAIT DISTURBANCE |
37 |
0.0002 |
| 682 |
PANIC ATTACK |
7 |
0.0002 |
| 683 |
DERMATITIS |
4 |
0.0002 |
| 684 |
MEMORY IMPAIRMENT |
26 |
0.0002 |
| 685 |
ANORECTAL DISCOMFORT |
1 |
0.0002 |
| 686 |
METABOLIC ACIDOSIS |
6 |
0.0002 |
| 687 |
BREAST PAIN |
2 |
0.0002 |
| 688 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
9 |
0.0002 |
| 689 |
LIVER FUNCTION TEST INCREASED |
4 |
0.0002 |
| 690 |
DECREASED ACTIVITY |
2 |
0.0002 |
| 691 |
INJURY |
13 |
0.0002 |
| 692 |
MULTIPLE FRACTURES |
3 |
0.0002 |
| 693 |
VISUAL ACUITY REDUCED |
6 |
0.0002 |
| 694 |
COAGULOPATHY |
3 |
0.0002 |
| 695 |
MENTAL STATUS CHANGES |
5 |
0.0002 |
| 696 |
NERVE INJURY |
2 |
0.0002 |
| 697 |
BLOOD UREA INCREASED |
3 |
0.0002 |
| 698 |
ANGIOPATHY |
1 |
0.0002 |
| 699 |
NEPHROPATHY TOXIC |
2 |
0.0002 |
| 700 |
STATUS EPILEPTICUS |
2 |
0.0002 |
| 701 |
HEART RATE IRREGULAR |
4 |
0.0002 |
| 702 |
MITRAL VALVE INCOMPETENCE |
2 |
0.0002 |
| 703 |
HAEMATURIA |
6 |
0.0002 |
| 704 |
ANGINA PECTORIS |
5 |
0.0002 |
| 705 |
DELIRIUM |
6 |
0.0002 |
| 706 |
MADAROSIS |
2 |
0.0002 |
| 707 |
NERVOUSNESS |
9 |
0.0002 |
| 708 |
ELECTROLYTE IMBALANCE |
2 |
0.0002 |
| 709 |
VASCULITIS |
2 |
0.0002 |
| 710 |
SPLENOMEGALY |
2 |
0.0002 |
| 711 |
BLOOD TRIGLYCERIDES INCREASED |
3 |
0.0002 |
| 712 |
BRADYKINESIA |
1 |
0.0002 |
| 713 |
GALLBLADDER DISORDER |
3 |
0.0002 |
| 714 |
HYPERLIPIDAEMIA |
2 |
0.0002 |
| 715 |
MUSCLE RIGIDITY |
2 |
0.0002 |
| 716 |
WRIST FRACTURE |
2 |
0.0002 |
| 717 |
HEPATITIS C |
2 |
0.0002 |
| 718 |
BONE DISORDER |
3 |
0.0002 |
| 719 |
HYPERCALCAEMIA |
2 |
0.0002 |
| 720 |
GENERALISED OEDEMA |
2 |
0.0002 |
| 721 |
PHARYNGITIS |
2 |
0.0002 |
| 722 |
PAIN |
99 |
0.0002 |
| 723 |
HEPATIC STEATOSIS |
3 |
0.0002 |
| 724 |
ILEUS |
2 |
0.0002 |
| 725 |
SEPTIC SHOCK |
7 |
0.0002 |
| 726 |
NERVOUS SYSTEM DISORDER |
5 |
0.0002 |
| 727 |
INJECTION SITE DISCOLOURATION |
2 |
0.0002 |
| 728 |
SECRETION DISCHARGE |
2 |
0.0002 |
| 729 |
HAEMATEMESIS |
4 |
0.0002 |
| 730 |
HEPATIC CYTOLYSIS |
2 |
0.0002 |
| 731 |
INTRAOCULAR PRESSURE INCREASED |
2 |
0.0002 |
| 732 |
PULMONARY FIBROSIS |
3 |
0.0002 |
| 733 |
POST PROCEDURAL COMPLICATION |
3 |
0.0002 |
| 734 |
LACTIC ACIDOSIS |
5 |
0.0002 |
| 735 |
AMNESIA |
10 |
0.0002 |
| 736 |
MUSCULOSKELETAL PAIN |
8 |
0.0002 |
| 737 |
ASPERGILLUS INFECTION |
1 |
0.0002 |
| 738 |
EYE DISORDER |
5 |
0.0002 |
| 739 |
IMMUNE SYSTEM DISORDER |
2 |
0.0002 |
| 740 |
PULMONARY CONGESTION |
2 |
0.0002 |
| 741 |
SARS-COV-2 TEST POSITIVE |
2 |
0.0002 |
| 742 |
HAEMATOCRIT DECREASED |
3 |
0.0002 |
| 743 |
ATRIOVENTRICULAR BLOCK COMPLETE |
1 |
0.0001 |
| 744 |
INJECTION SITE PRURITUS |
10 |
0.0001 |
| 745 |
JOINT RANGE OF MOTION DECREASED |
2 |
0.0001 |
| 746 |
BREAST MASS |
1 |
0.0001 |
| 747 |
DYSKINESIA |
6 |
0.0001 |
| 748 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
1 |
0.0001 |
| 749 |
PNEUMONITIS |
4 |
0.0001 |
| 750 |
IMPAIRED GASTRIC EMPTYING |
2 |
0.0001 |
| 751 |
ABNORMAL LOSS OF WEIGHT |
1 |
0.0001 |
| 752 |
RIB FRACTURE |
3 |
0.0001 |
| 753 |
CENTRAL NERVOUS SYSTEM LESION |
2 |
0.0001 |
| 754 |
ALOPECIA |
28 |
0.0001 |
| 755 |
HYPERKALAEMIA |
5 |
0.0001 |
| 756 |
BACK PAIN |
33 |
0.0001 |
| 757 |
SEASONAL ALLERGY |
2 |
0.0001 |
| 758 |
LYMPHADENOPATHY |
5 |
0.0001 |
| 759 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
4 |
0.0001 |
| 760 |
IRRITABLE BOWEL SYNDROME |
3 |
0.0001 |
| 761 |
RED BLOOD CELL COUNT DECREASED |
4 |
0.0001 |
| 762 |
CONVULSION |
8 |
0.0001 |
| 763 |
HYPERSOMNIA |
4 |
0.0001 |
| 764 |
POOR QUALITY SLEEP |
3 |
0.0001 |
| 765 |
ANOSMIA |
2 |
0.0001 |
| 766 |
COMPLICATION ASSOCIATED WITH DEVICE |
2 |
0.0001 |
| 767 |
CRYING |
5 |
0.0001 |
| 768 |
ABDOMINAL DISCOMFORT |
23 |
0.0001 |
| 769 |
NEUROPATHY PERIPHERAL |
13 |
0.0001 |
| 770 |
ASCITES |
4 |
0.0001 |
| 771 |
ILLNESS |
14 |
0.0001 |
| 772 |
SKIN HAEMORRHAGE |
2 |
0.0001 |
| 773 |
SOMNOLENCE |
27 |
0.0001 |
| 774 |
GLOSSODYNIA |
3 |
0.0001 |
| 775 |
BLOOD POTASSIUM DECREASED |
4 |
0.0001 |
| 776 |
AORTIC ANEURYSM |
1 |
0.0001 |
| 777 |
RENAL IMPAIRMENT |
11 |
0.0001 |
| 778 |
TENDONITIS |
2 |
0.0001 |
| 779 |
BRONCHOPULMONARY ASPERGILLOSIS |
1 |
0.0001 |
| 780 |
EJECTION FRACTION DECREASED |
2 |
0.0001 |
| 781 |
MENINGIOMA |
2 |
0.0001 |
| 782 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
2 |
0.0001 |
| 783 |
MIGRAINE |
12 |
0.0001 |
| 784 |
ABSCESS |
2 |
0.0001 |
| 785 |
FATIGUE |
97 |
0.0001 |
| 786 |
ACUTE KIDNEY INJURY |
19 |
0.0001 |
| 787 |
OEDEMA PERIPHERAL |
15 |
0.0001 |
| 788 |
CEREBRAL INFARCTION |
3 |
0.0001 |
| 789 |
LIVER INJURY |
3 |
0.0001 |
| 790 |
ABNORMAL FAECES |
1 |
0.0001 |
| 791 |
DYSPEPSIA |
12 |
0.0001 |
| 792 |
ABDOMINAL PAIN UPPER |
25 |
0.0001 |
| 793 |
PHOTOSENSITIVITY REACTION |
2 |
0.0001 |
| 794 |
INJECTION SITE ERYTHEMA |
15 |
0.0001 |
| 795 |
DRUG LEVEL INCREASED |
2 |
0.0001 |
| 796 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
3 |
0.0001 |
| 797 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 798 |
INFUSION RELATED REACTION |
8 |
0.0001 |
| 799 |
RENAL FAILURE |
16 |
0.0001 |
| 800 |
PNEUMONIA ASPIRATION |
3 |
0.0001 |
| 801 |
POLLAKIURIA |
5 |
0.0001 |
| 802 |
GAIT INABILITY |
4 |
0.0001 |
| 803 |
PRODUCT COMPLAINT |
3 |
0.0001 |
| 804 |
HYPOPHAGIA |
3 |
0.0001 |
| 805 |
INSOMNIA |
31 |
0.0001 |
| 806 |
INFLAMMATION |
6 |
0.0001 |
| 807 |
HAEMATOMA |
3 |
0.0001 |
| 808 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
3 |
0.0001 |
| 809 |
BLOOD CALCIUM INCREASED |
1 |
0.0001 |
| 810 |
PANCREATITIS |
6 |
0.0001 |
| 811 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
4 |
0.0001 |
| 812 |
FEAR |
3 |
0.0001 |
| 813 |
BLOOD BILIRUBIN INCREASED |
3 |
0.0001 |
| 814 |
LIMB INJURY |
3 |
0.0001 |
| 815 |
PYREXIA |
38 |
0.0001 |
| 816 |
END STAGE RENAL DISEASE |
2 |
0.0001 |
| 817 |
ACCIDENTAL OVERDOSE |
4 |
0.0001 |
| 818 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
2 |
0.0001 |
| 819 |
MYOCARDIAL INFARCTION |
19 |
0.0001 |
| 820 |
BRAIN NEOPLASM |
1 |
0.0001 |
| 821 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
0.0001 |
| 822 |
DYSURIA |
4 |
0.0001 |
| 823 |
HAEMOPTYSIS |
3 |
0.0001 |
| 824 |
THINKING ABNORMAL |
2 |
0.0001 |
| 825 |
MIDDLE INSOMNIA |
2 |
0.0001 |
| 826 |
TOXICITY TO VARIOUS AGENTS |
18 |
0.0001 |
| 827 |
HYPOCALCAEMIA |
2 |
0.0001 |
| 828 |
FOOT FRACTURE |
2 |
0.0001 |
| 829 |
ABDOMINAL DISTENSION |
11 |
0.0001 |
| 830 |
BLOOD URINE PRESENT |
2 |
0.0001 |
| 831 |
SLEEP APNOEA SYNDROME |
2 |
0.0001 |
| 832 |
INJECTION SITE SWELLING |
8 |
0.0001 |
| 833 |
DYSTONIA |
2 |
0.0001 |
| 834 |
KIDNEY INFECTION |
2 |
0.0001 |
| 835 |
LABORATORY TEST ABNORMAL |
3 |
0.0001 |
| 836 |
ADVERSE DRUG REACTION |
9 |
0.0001 |
| 837 |
SLEEP DISORDER |
7 |
0.0001 |
| 838 |
NEUTROPHIL COUNT DECREASED |
4 |
0.0001 |
| 839 |
TOOTH LOSS |
2 |
0.0001 |
| 840 |
DIARRHOEA |
62 |
0.0001 |
| 841 |
BONE DENSITY DECREASED |
3 |
0.0001 |
| 842 |
GENERAL PHYSICAL HEALTH DETERIORATION |
11 |
0.0001 |
| 843 |
MOVEMENT DISORDER |
3 |
0.0001 |
| 844 |
FAECES DISCOLOURED |
2 |
0.0001 |
| 845 |
OEDEMA |
5 |
0.0001 |
| 846 |
CHRONIC KIDNEY DISEASE |
7 |
0.0001 |
| 847 |
MENTAL DISORDER |
4 |
0.0001 |
| 848 |
IMPAIRED HEALING |
3 |
0.0001 |
| 849 |
OSTEONECROSIS |
3 |
0.0001 |
| 850 |
ASPIRATION |
1 |
0.0001 |
| 851 |
FEBRILE NEUTROPENIA |
6 |
0.0001 |
| 852 |
LIVER DISORDER |
4 |
0.0001 |
| 853 |
TRANSAMINASES INCREASED |
2 |
0.0001 |
| 854 |
URINARY RETENTION |
3 |
0.0001 |
| 855 |
PANCREATITIS ACUTE |
2 |
0.0001 |
| 856 |
CHROMATURIA |
2 |
0.0001 |
| 857 |
NEPHROLITHIASIS |
4 |
0.0001 |
| 858 |
NEOPLASM PROGRESSION |
3 |
0.0001 |
| 859 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
2 |
0.0001 |
| 860 |
BACTERAEMIA |
1 |
0.0001 |
| 861 |
PRODUCT PRESCRIBING ERROR |
2 |
0.0001 |
| 862 |
IRRITABILITY |
5 |
0.0001 |
| 863 |
SKIN EXFOLIATION |
7 |
0.0001 |
| 864 |
DRY SKIN |
11 |
0.0001 |
| 865 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
| 866 |
LUNG DISORDER |
4 |
0.0001 |
| 867 |
OFF LABEL USE |
71 |
0.0001 |
| 868 |
EPISTAXIS |
6 |
0.0001 |
| 869 |
GASTROINTESTINAL DISORDER |
7 |
0.0001 |
| 870 |
ERECTILE DYSFUNCTION |
2 |
0.0001 |
| 871 |
ACCIDENTAL EXPOSURE TO PRODUCT |
8 |
0.0001 |
| 872 |
ANHEDONIA |
2 |
0.0001 |
| 873 |
JAUNDICE |
2 |
0.0001 |
| 874 |
WHITE BLOOD CELL COUNT DECREASED |
8 |
0.0001 |
| 875 |
BLINDNESS |
3 |
0.0001 |
| 876 |
AKATHISIA |
1 |
0.0001 |
| 877 |
DECREASED APPETITE |
17 |
0.0001 |
| 878 |
OSTEOPOROSIS |
3 |
0.0001 |
| 879 |
PROCEDURAL PAIN |
2 |
0.0001 |
| 880 |
DEPRESSION |
16 |
0.0001 |
| 881 |
INTERNATIONAL NORMALISED RATIO INCREASED |
2 |
0.0001 |
| 882 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
2 |
0.0001 |
| 883 |
APATHY |
1 |
0.0001 |
| 884 |
INJECTION SITE PAIN |
21 |
0.0001 |
| 885 |
ACUTE MYOCARDIAL INFARCTION |
2 |
0.0001 |
| 886 |
RENAL INJURY |
2 |
0.0001 |
| 887 |
HEPATIC FAILURE |
2 |
0.0001 |
| 888 |
PRODUCT QUALITY ISSUE |
9 |
0.0001 |
| 889 |
DEATH |
57 |
0.0001 |
| 890 |
CONTRAINDICATED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 891 |
ILL-DEFINED DISORDER |
4 |
0.0001 |
| 892 |
PLEURAL EFFUSION |
4 |
0.0001 |
| 893 |
SUICIDAL IDEATION |
6 |
0.0001 |
| 894 |
ALANINE AMINOTRANSFERASE INCREASED |
4 |
0.0001 |
| 895 |
HYPOKALAEMIA |
3 |
0.0001 |
| 896 |
ANKLE FRACTURE |
1 |
0.0001 |
| 897 |
RENAL DISORDER |
3 |
0.0001 |
| 898 |
SEPSIS |
7 |
0.0001 |
| 899 |
CONTUSION |
6 |
0.0001 |
| 900 |
THROMBOSIS |
5 |
0.0001 |
| 901 |
BACK DISORDER |
1 |
0.0001 |
| 902 |
WEIGHT DECREASED |
17 |
0.0001 |
| 903 |
STAPHYLOCOCCAL INFECTION |
2 |
0.0001 |
| 904 |
EXPIRED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 905 |
CELLULITIS |
3 |
0.0001 |
| 906 |
TRANSIENT ISCHAEMIC ATTACK |
2 |
0.0001 |
| 907 |
FLUID RETENTION |
3 |
0.0001 |
| 908 |
ANAEMIA |
11 |
0.0001 |
| 909 |
DEVICE USE ERROR |
2 |
0.0001 |
| 910 |
ECZEMA |
3 |
0.0001 |
| 911 |
AMENORRHOEA |
1 |
0.0001 |
| 912 |
DERMATITIS ATOPIC |
3 |
0.0001 |
| 913 |
PRODUCT USE IN UNAPPROVED INDICATION |
14 |
0.0001 |
| 914 |
ASPARTATE AMINOTRANSFERASE INCREASED |
3 |
0.0001 |
| 915 |
PLATELET COUNT DECREASED |
6 |
0.0001 |
| 916 |
OVERDOSE |
12 |
0.0001 |
| 917 |
ELECTROCARDIOGRAM QT PROLONGED |
2 |
0.0001 |
| 918 |
HYPERGLYCAEMIA |
2 |
0.0001 |
| 919 |
INJECTION SITE MASS |
2 |
0.0001 |
| 920 |
FALL |
18 |
0.0001 |
| 921 |
MEDICATION ERROR |
3 |
0.0001 |
| 922 |
PANCYTOPENIA |
3 |
0.0001 |
| 923 |
HEPATIC FUNCTION ABNORMAL |
2 |
0.0001 |
| 924 |
CEREBROVASCULAR ACCIDENT |
9 |
0.0001 |
| 925 |
DYSPNOEA EXERTIONAL |
2 |
0.0001 |
| 926 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 927 |
FLATULENCE |
3 |
0.0001 |
| 928 |
COLITIS |
2 |
0.0001 |
| 929 |
ACNE |
4 |
0.0001 |
| 930 |
PULMONARY EMBOLISM |
5 |
0.0001 |
| 931 |
DEHYDRATION |
7 |
0.0001 |
| 932 |
WHITE BLOOD CELL COUNT INCREASED |
2 |
0.0001 |
| 933 |
ATRIAL FIBRILLATION |
5 |
0.0001 |
| 934 |
PLASMA CELL MYELOMA |
2 |
0.0001 |
| 935 |
ARTHRITIS |
4 |
0.0001 |
| 936 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
1 |
0.0001 |
| 937 |
ABNORMAL BEHAVIOUR |
2 |
0.0001 |
| 938 |
ABORTION SPONTANEOUS |
2 |
0.0000 |
| 939 |
EXTRA DOSE ADMINISTERED |
2 |
0.0000 |
| 940 |
BONE MARROW FAILURE |
1 |
0.0000 |
| 941 |
RHABDOMYOLYSIS |
2 |
0.0000 |
| 942 |
BLOOD GLUCOSE INCREASED |
9 |
0.0000 |
| 943 |
CONDITION AGGRAVATED |
14 |
0.0000 |
| 944 |
DRUG INEFFECTIVE |
60 |
0.0000 |
| 945 |
MATERNAL EXPOSURE DURING PREGNANCY |
4 |
0.0000 |
| 946 |
COLITIS ULCERATIVE |
2 |
0.0000 |
| 947 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 948 |
THERAPY NON-RESPONDER |
2 |
0.0000 |
| 949 |
APPLICATION SITE PRURITUS |
1 |
0.0000 |
| 950 |
INCORRECT DOSE ADMINISTERED |
10 |
0.0000 |
| 951 |
SKIN IRRITATION |
2 |
0.0000 |
| 952 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 953 |
BLOOD CHOLESTEROL INCREASED |
2 |
0.0000 |
| 954 |
CARDIAC DISORDER |
4 |
0.0000 |
| 955 |
BLOOD GLUCOSE DECREASED |
2 |
0.0000 |
| 956 |
JOINT SWELLING |
5 |
0.0000 |
| 957 |
DRUG INTOLERANCE |
4 |
0.0000 |
| 958 |
HYPOGLYCAEMIA |
2 |
0.0000 |
| 959 |
ABASIA |
1 |
0.0000 |
| 960 |
AGGRESSION |
2 |
0.0000 |
| 961 |
MALIGNANT NEOPLASM PROGRESSION |
4 |
0.0000 |
| 962 |
HAEMOGLOBIN DECREASED |
4 |
0.0000 |
| 963 |
DEPRESSED MOOD |
2 |
0.0000 |
| 964 |
BREAST CANCER FEMALE |
1 |
0.0000 |
| 965 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0000 |
| 966 |
HAEMATOCHEZIA |
2 |
0.0000 |
| 967 |
ARTHROPATHY |
2 |
0.0000 |
| 968 |
STOMATITIS |
2 |
0.0000 |
| 969 |
NASOPHARYNGITIS |
6 |
0.0000 |
| 970 |
WEIGHT INCREASED |
7 |
0.0000 |
| 971 |
PNEUMONIA |
10 |
0.0000 |
| 972 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
| 973 |
URINARY TRACT INFECTION |
5 |
0.0000 |
| 974 |
INJECTION SITE REACTION |
2 |
0.0000 |
| 975 |
INFECTION |
4 |
0.0000 |
| 976 |
NO ADVERSE EVENT |
5 |
0.0000 |
| 977 |
CONSTIPATION |
6 |
0.0000 |
| 978 |
THROMBOCYTOPENIA |
3 |
0.0000 |
| 979 |
HALLUCINATION |
2 |
0.0000 |
| 980 |
INJECTION SITE HAEMORRHAGE |
2 |
0.0000 |
| 981 |
CARDIAC FAILURE |
2 |
0.0000 |
| 982 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 983 |
FOETAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 984 |
GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0000 |
| 985 |
NEUTROPENIA |
3 |
0.0000 |
| 986 |
BREAST CANCER |
2 |
0.0000 |
| 987 |
SINUSITIS |
2 |
0.0000 |
| 988 |
HAEMORRHAGE |
2 |
0.0000 |
| 989 |
DRUG DEPENDENCE |
3 |
0.0000 |
| 990 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
3 |
0.0000 |
| 991 |
PSORIASIS |
2 |
0.0000 |
| 992 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
3 |
0.0000 |
| 993 |
PRODUCT DOSE OMISSION ISSUE |
4 |
0.0000 |
| 994 |
COVID-19 |
2 |
0.0000 |